[
  {
    "ts": null,
    "headline": "Why Johnson & Johnson Could Be the Ultimate Dividend King",
    "summary": "Johnson & Johnson has increased its dividend every year for 63 consecutive years. It doesn't want to stop.",
    "url": "https://finnhub.io/api/news?id=8986707e5ee747146ef5f272af0f22f18783642ed8a3b57345bb9d57a4105894",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759097700,
      "headline": "Why Johnson & Johnson Could Be the Ultimate Dividend King",
      "id": 136913615,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson has increased its dividend every year for 63 consecutive years. It doesn't want to stop.",
      "url": "https://finnhub.io/api/news?id=8986707e5ee747146ef5f272af0f22f18783642ed8a3b57345bb9d57a4105894"
    }
  },
  {
    "ts": null,
    "headline": "Is There Still Room for Growth in J&J Shares After Recent FDA Approval?",
    "summary": "Trying to figure out whether to hold, buy, or trim your Johnson & Johnson position? You are definitely not alone. This blue chip stock has a long history of resilience, but recent price movements have caused both excitement and caution among investors. Over just the past week, shares have climbed 2.0%, building on steady gains that have pushed the stock up 1.4% over the last month. More impressively, year-to-date, Johnson & Johnson has surged 24.8%. Many longtime holders are pleased with a...",
    "url": "https://finnhub.io/api/news?id=25f132bc2907c49832a345876d2a1bdac400977bce7104ae5d9407e02727a2c0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759057590,
      "headline": "Is There Still Room for Growth in J&J Shares After Recent FDA Approval?",
      "id": 136907490,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Trying to figure out whether to hold, buy, or trim your Johnson & Johnson position? You are definitely not alone. This blue chip stock has a long history of resilience, but recent price movements have caused both excitement and caution among investors. Over just the past week, shares have climbed 2.0%, building on steady gains that have pushed the stock up 1.4% over the last month. More impressively, year-to-date, Johnson & Johnson has surged 24.8%. Many longtime holders are pleased with a...",
      "url": "https://finnhub.io/api/news?id=25f132bc2907c49832a345876d2a1bdac400977bce7104ae5d9407e02727a2c0"
    }
  },
  {
    "ts": null,
    "headline": "Best Dividend Aristocrats For October 2025",
    "summary": "Dividend Aristocrats, tracked by NOBL, outperformed SPY in August but lagged year-to-date. Check out the promising dividend aristocrats right now.",
    "url": "https://finnhub.io/api/news?id=80b94346d4f08aadcb8ef4dd3c6f559e7efa52d69d34269d73cbad8d41f46360",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759021200,
      "headline": "Best Dividend Aristocrats For October 2025",
      "id": 136904977,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2148089915/image_2148089915.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Dividend Aristocrats, tracked by NOBL, outperformed SPY in August but lagged year-to-date. Check out the promising dividend aristocrats right now.",
      "url": "https://finnhub.io/api/news?id=80b94346d4f08aadcb8ef4dd3c6f559e7efa52d69d34269d73cbad8d41f46360"
    }
  }
]